Apoptosis (programmed cell death) is an important process which, in conjunction with cell proliferation, maintains cell number homeostasis. Although apoptosis has been more extensively investigated in other tissues [1,2], only recently has this process been suspected as a significant contributor to both disease and normal development of the cardiovascular system [3][4][5][6]. Grasping a comprehension of the underlying genetic mechanisms of apoptosis is especially crucial considering that cardiac myocytes irreversibly exit the cell cycle and thus fail to proliferate during pathological conditions. Despite great strides in understanding the molecular pathways of apoptosis, there still remain numerous questions to be answered. Identifying key genes that are involved in the regulatory process of apoptosis in the cardiovascular system will serve as a basis for creating more effective therapeutic treatments in cardiovascular disease and provide an understanding of how cardiac development is modulated. This review provides a brief summary of recent data implicating genes that may be involved in apoptosis in the cardiovascular system. It also outlines the continued usefulness of large-scale generation of expressed sequence tags (ESTs) to establish expression profiles from the cardiovascular system and as a means of identifying potentially significant apoptotic regulators previously characterized in other tissues but not as yet in the cardiovascular system.
Introduction
necrosis and apoptosis is the inflammatory response: cellular debris is accumulated in necrotic cells, whereas in Cell death can occur either by necrosis or apoptosis.
apoptotic cells there exists an efficient degradation and Apoptotic and necrotic cells are generally different in disposal process through phagocytosis by neighboring morphology and in the sequence of events surrounding cells. Apoptosis is essential for normal development their demise. Morphologically, necrosis is characterized by through its involvement in controlling cell number homeocell lysis and organelle destruction, whereas apoptosis stasis in conjunction with cell proliferation. However, this results in cell shrinkage, blebbing, chromatin condensation balance can be perturbed leading to abnormal, often fatal and DNA fragmentation [7] . The major difference between conditions (such as embryonic lethality) [8, 9] ; recent studies have sought to identify modulators of apoptosis in an attempt to decipher how the process can be positively or negatively regulated. Early work in the nematode C. elegans [10,11; for reviews see 12,13] has provided significant preliminary data in understanding the more are described here, including recent data from those complex regulation in higher organisms, such as in mamcharacterized further in our laboratory. Individual genes malian systems.
are classified according to their function as described in the Apoptosis can be initiated or controlled by developmenliterature. tal and environmental factors such as DNA damage, viral infection, cellular damage and loss of cell-cell or cell-2.1. Interleukin-converting enzyme (ICE) family: substrate contact; it is also under the regulation of a caspases number of genes. These regulatory genes can be classified into 3 categories:
The discovery of death effector genes in C. elegans, namely ced-3 and ced-4 [17, 18] , provided an important 1. Effectors of apoptosis (e.g., interleukin-1-beta convertfoundation for understanding how apoptosis could be ing enzyme (ICE) family), which are implicated in the carried out in higher organisms. The ced-3 protein was onset of apoptosis.
found to be homologous to a mammalian cysteine protease 2. Suppressors of apoptosis (e.g., Bcl-2), which are very known as interleukin-1beta-converting enzyme (ICE), now important for the regulation of apoptosis and are considered a prototype of the caspase (ICE / Ced-3) family involved in pathogenesis of many diseases such as of proteins. To date there are at least 14 known human lymphomas and leukemia [14, 15] . members of this family [19] , and studies have shown that 3. Intermediate regulators of apoptosis (e.g., Fas / Fas caspases are primary death effectors that can be inhibited ligand, p53 and c-myc), which can interact with reto block apoptosis [20] . Consequent to cellular apoptotic ceptor complexes and other apoptotic regulators to inducement, caspase proforms are proteolytically cleaved induce or suppress apoptosis.
to generate activated forms of the enzyme. Typically, these enzymes are activated by other members of the ICE family To obtain a profile of genes expressed in the carsuch as the positive regulator caspase-2 (ICH-1 / NEDD-2), diovascular system from a developmental (fetal vs. adult whose proform is cleaved by a caspase-3 (CPP32)-like heart) and disease (normal adult vs. hypertrophic heart) protease [21] . perspective, large-scale sequencing of expressed sequence Recently, caspases have been found to play an important tags (ESTs) from human cardiovascular cDNA libraries role in regulating apoptosis in the cardiovascular system has been investigated. To date, our laboratory has se-(for a review, see Ref. [22] ), particularly in vascular quenced over 51 000 ESTs from these libraries, and a smooth muscle cells [23] and cardiac cells. In vitro, catalogue of over 5000 genes from the cardiovascular apoptosis induced in cultured rat myocytes was attenuated system and a profile of their differential expression has with ZVAD-fmk, a caspase-specific inhibitor [24] ; caspasebeen published [16] . From this, genes that are known to be 3 was found to be present in staurosporine-induced apoinvolved in apoptotic pathways -either as effectors, ptotic cells, implicating this family member as an effector suppressors or intermediate regulators -can be identified of apoptosis. in the cardiovascular system and further characterized.
Two members of the ICE family may provide further insight into a link between apoptosis regulation and cardiac development. Ich-1L and Ich-1S, also known as caspase-2, 2. Genes involved in apoptosis -a cardiovascular has been uncovered through random sequencing of a heart perspective cDNA library [16] . These genes represent two Ich-1 mRNA species that have been reported through alternative The control of apoptosis has been linked to a variety of splicing: Ich-1L, a gene encoding a 435 amino acid protein genes and gene families. Differential expression of these that induces programmed cell death; and Ich-1S, a trungenes between tissues, developmental and disease states cated version of Ich-1L whose overexpression suppresses and, indeed, between organisms, has been studied to apoptosis [25] . establish pathway(s) of apoptotic regulation. From our data, we have extracted and modified two specific func-2.2. Bcl-2 family tional subsets of genes identified in the cardiovascular system [16], namely 'apoptosis' (Table 1a) and 'DNA Spawning from previous work in the nematode C. synthesis / replication' (Table 1b) . In Table 1a , the genes elegans, a homologue to the death suppressor gene ced-9 were further characterized based on their mode of apowas identified in mammals which was found to be signifiptotic regulation as described previously in the literature, cant in maintaining cell survival in human B-cell lymnamely 'effectors', 'suppressors' or 'intermediate regphoma [14, 26, 27] . Named Bcl-2, this gene served as a ulators' of apoptosis. The two subsets were selected since prototype for a large family of related apoptotic regulators, both apoptosis and DNA synthesis / replication are involved including various isoforms and homologues (e.g., Bcl-xL / in controlling cell number homeostasis.
Bcl-xS, Bax, Bad, Bak, Bik, etc.) which function to The genes and gene families idenitified in our database promote death or, like Bcl-2, possess anti-apoptotic activi-ty. A striking feature of the Bcl-2 family (and one that has myocardial ischemia may not be as significant as suggested helped pave the way for the discovery of novel family previously, considering that it also functions to attenuate members) is the ability of the molecules to form homoapoptosis under anaerobic conditions [29] . Consequently, dimers and heterodimers, a trait that appears to play a alternative mechanisms of apoptosis in this condition have significant role in controlling apoptosis [28, 29] . Identifying been investigated. Both H O and O -were found to 2 2 2 the differential expression of these genes is crucial in induce apoptosis in isolated cardiac cells but without a understanding how cell number balance is upset in carconcomitant increase in Bcl-2 or Bax protein levels; diovascular development and / or disease.
furthermore, H O induces an upregulation of Bad protein, 2 2
The involvement of Bcl-2 family members in ischemia following which, Bad and Bax form heterodimers with and oxidative stress is significant [30, 31] , although the Bcl-2 [32] . It appears, however, that this pathway is exact mechanism by which apoptosis is signalled remains a independent from those triggered by free radicals (e.g., mystery. Early work reported that Bcl-2 may play an O -) and suggests a more complex underlying mechanism 2 important role in preventing cell death through the of apoptotic response. Support for this lies in the findings scavenging of free radicals, but a direct involvement in that Bcl-2 and NFkappaB are differentially regulated in Table 1 In Silico Northern analysis of known genes expressed in the human cardiovascular system: a) genes involved in apoptosis; and b) genes involved in cell division (DNA synthesis / replication a Accession numbers listed correspond to the putatively identified gene. In the event that an EST matched to more than one entry, the entry with the 210 greatest number of EST hits was chosen. ESTs matching significantly to GenBank database entries (P,10 ) but exhibiting ,95% sequence identity were designated as homologs of the most significant match. ESTs matching significantly only to non-human GenBank database entries were designated as isologs of those genes. Intensities reflect the frequency of a given EST in a particular library, as a percentage of total ESTs in that library. Intensities are defined as follows: response to ischemia and reperfusion. During repeated chemia, although the involvement of each component cyclic episodes of short-term ischemia followed by a short remains to be fully elucidated. period of reperfusion, cardiomyocyte apoptosis and DNA Consistent with these data, we have identified several fragmentation were reduced; associated with increased Bcl-2 family members in our heart databases. In addition expression of Bcl-2 mRNA and activation of NFkappaB to Bcl-2 itself and related proteins, other genes that have [33] . Thus, Bcl-2 and its family members appear to have been found to be expressed in the cardiovascular system crucial roles in the progression of apoptosis during is- (Table 1a) including Bcl-2-binding component 6, Bak, Bcl-x, and BID (identified in a human endothelial cell analysis has shown that DAD-1 is more highly expressed library; data not shown). Bak and Bcl-x have recently been in cardiac hypertrophy compared to normal adult heart, and implicated in cytokine-induced cardiac myocyte apoptosis thus may play a role in controlling cell numbers during [34] . BID, a BH3 domain-containing death agonist protein disease. In fact, of the apoptotic regulators identified in our [35] , binds to other family member proteins (especially database, DAD-1 was the only gene found to be expressed Bax and Bcl-2) to induce apoptosis [36] .
Intensity Frequency
in a hypertrophic heart library ( The Fas / TNF receptor system is rapidly becoming well contribute to cell survival [38] . However, Nip 3 (nineteen understood and recent studies have implicated members of kDa interacting protein-3) is a homodimerizing Bcl-2 this protein family in a variety of cardiovascular diseases: binding protein [39] and a potent mitochondrial mema) dilated cardiomyopathy was found to have a significant brane-bound pro-apoptotic regulator found to overcome positive correlation with Fas expression and apoptosis suppressor effects of Bcl-2 [40] .
from the myocytes of patients with this condition [52]; b) increased FasL expression in inflammatory disease, reflect-2.3.1.3. Stannin Stannin is a protein involved in the ing the role of apoptosis in autoimmune myocarditis [53-neurotoxicity of trimethylin, a potent chemical that dam-55]; c) Fas was found to be expressed in a fetal heart ages neurons in the nervous system [41] . Stannin is highly cDNA library [16] . Within the complex of the Fas receptor expressed in apoptotic neuronal cells, implying a role for system, FAF1 associates with the cytoplasmic domain of this protein in neurovascular pathology. Although Northern FAS and has been found to potentiate apoptosis in mice blot failed to detect any appreciable levels of stannin [56] . TDAG51 (see Table 1a ; identified in a human aorta mRNA in rat heart [42], the finding of a stannin isolog in a cDNA library, results not shown) also interacts with Fas to human fetal heart cDNA library reveals the benefits of induce apoptosis in T-lymphocytes [57] . Further studies large-scale sequencing in discovering low-expressed genes, will confirm their involvement in cardiovascular apoptosis. as stannin may be expressed at a level below the detection The TNF-alpha receptor system is especially interesting limit of Northern blot.
for modulating apoptosis as it appears to serve a dual function: not only does it induce apoptosis through medi-2.3.2. Suppressors ators such as FADD, it also can act as an apoptotic suppressor via the activation of NFkappaB. Originally 2.3.2.1. DAD-1 In hamster cell lines, a mutant form of identified in baculoviruses, homologous mammalian inhib-DAD-1 was found to induce apoptosis, suggesting a role itory apoptotic proteins (IAPs) have been identified and for this protein as an apoptotic suppressor [43] . In silico characterized. IAP1 and IAP2 interact with a heterocom-plex formed from TNFR2 signal transducers and TNFhibited by members of the Bcl-2 family [73] . Exposure of receptor associated factors TRAF1 and TRAF2 [58] . The myocytes to H O and O --and thus stimulating 2 2 2 duality of TNFR apoptotic modulation is apparent in Tapoptosis -has resulted in increased levels of p53 protein lymphocyte death from aging: increased expression of [32] . p53 activates Bax and represses Bcl-2, and may work TNFR1 and TRADD coupled with activation of caspases 3 to induce apoptosis through upregulation of the reninand 8, and a decreased expression of TNFR2 and TRAF2 angiotensin system, as observed in rat cardiomyocytes was observed in cells from lymphocytes taken from aged which showed increased levels of angiotensinogen and humans where there exists increased apoptosis [59] .
angiotensin II AT1 receptor, and a consequent 14-fold increase in angiotensin-II expression [74] . Our preliminary RT-PCR results have indicated a differential expression of 2.3.4. p38 family member p38-2G4 p53 mRNA during human heart development as well as in Members of the p38 family have been shown to play cardiac hypertrophy (unpublished data; results not shown). significant roles in regulating apoptosis in cardiovascular Finding therapeutic agents that may control the level of disease. Expression of p38 mitogen-activated protein kip53-induced apoptosis may be very important in reducing nase (MAPK) was found to be higher in cardiac hythe consequences of cardiac injury (for review see Ref. pertrophy [60] and during ischemia [61] . Inhibiting p38 [75] ).
MAPK during ischemia significantly reduces apoptosis and
In silico Northern analysis has identified a gene, WAF1, injury following reperfusion [62] . We have identified in our which is directly induced by p53. It contains a p53-binding database a clone representing p38-2G4, a mammalian site in its promoter region and was shown to reduce human proliferation-associated nuclear protein which is modified tumors in culture [76] . during the cell cycle and was previously observed in murine macrophages [63] . Although not a MAPK, this gene represents an interesting novel member of the p38 2.4.3. APC family with regard to cell regulation.
The tumor suppressor protein adenomatosis polyposis coli (APC) was first identified in the cardiovascular system in April, 1996, (accession number N85172; Ref.
[16]) and 2.4. Apoptotic genes studied in our laboratory its expression confirmed by RT-PCR [77, 78] . In an attempt to characterize the role of APC in the cardiovascu-2.4.1. Zinc finger proteins lar system, we have generated preliminary data from a Recent studies have implicated members of the zinc recent study that indicates a possible involvement of APC finger protein (ZFP) family of transcription factors in the in the apoptotic process in vitro (manuscript submitted for positive or negative regulation of apoptosis. For example, publication). Inhibition of APC expression by antisense extensive apoptosis has been reported in cells a) lacking oligonucleotides drastically altered the cellular prolifer-GATA-1 function [64] , and b) overexpressing PAG608 ation rate, reducing the number of cells during the course [65] , Sp1 [66] , ZK1 [67] , Requiem [68] and WT1 [69] .
of the experiment. In addition, there appeared to be higher Although several ZFPs have been functionally linked to cell death in antisense treatment by virtue of a greater apoptosis, the precise regulatory networks of apoptotic number of detached cells. This suggests that APC may also pathways are still not well understood. To understand the be involved in programmed cell death (i.e., apoptosis) pathological mechanisms of heart failure and the insimilar to what has been previously observed with many volvement of apoptosis, extensive studies of cardiovascular other tumor suppressors. For example, transcription factors ZFP regulatory networks are required. As an initial step such as c-myc are intimately associated with cellular toward this goal, a recently established profile of ZFPs proliferation as its constitutive expression increases the from heart cDNA libraries could be used as a significant susceptibility of cells to apoptosis [79] . Interestingly, a resource of ZFP expression data [70] . Elucidating the recent study has shown that APC is involved in the c-myc function of these and other genes identified in the profile pathway [80] , providing further evidence for a possible may pave the way in understanding the role of ZFPs in link between APC and apoptotic regulation. apoptotic regulatory pathways of the heart and will help clarify the pathogenesis of cardiovascular disease.
Summary and future directions 2.4.2. p53
The tumor suppressor DNA-binding protein p53 is Large-scale EST sequencing of heart cDNA libraries has widely known as an intermediate effector of apoptosis. It is proven to be a successful means of identifying key involved in mechanisms of growth arrest and apoptosis, regulatory genes involved in cardiovascular development and may stimulate cell death in response to DNA damage and disease [16, 81, 82] . This method has allowed us to [71, 72] ing cardiomyoctye re-entry into the cell cycle. Since number, the focus of investigations should also be directed regulating DNA synthesis and replication mirror those that to a more robust result. Gene expression profiles will no Further investigation into novel genes may reveal previ- diovascular disease.
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